Press Releases NovAccess Global Inc.

Equities

XSNX

US67001N1072

Market Closed - OTC Markets Other stock markets 20:59:58 10/05/2024 BST			5-day change	1st Jan Change
0.007 ^USD	+16.67%		+7.69%	-65.17%

04-29	NovAccess Global Inc. announced that it has received $0.0265 million in funding from AJB Capital Investments LLC	CI
02-27	NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NovAccess Global : Announces New License to Advance its Immunotherapy Platform	04-30	PU
NovAccess Global Announces $10.7 Million Financing	01-03	AQ
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	12-01	NE
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	28/07/23	AQ
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	13/07/23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23/06/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	12/06/23	AQ
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	12/05/23	AQ
NovAccess Global : Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	11/05/23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/05/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18/04/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	16/03/23	AQ
NovAccess Global : Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award	15/03/23	PU
NovAccess Global to Present at World Orphan Drug Congress	17/02/23	AQ
NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/02/23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	13/02/23	AQ
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress	06/02/23	AQ
NovAccess Global : Material Agreement - Form 8-K	24/01/23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23/01/23	AQ
NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	10/01/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NovAccess Global Inc.

Equities

XSNX

US67001N1072

Press Releases

Filters